Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -790,155 | -23,363 | -17,633 | -20,538 | -14,677 |
| Depreciation Amortization | 7,328 | 25,983 | 19,473 | 12,968 | 6,485 |
| Accounts receivable | -12,886 | -48,055 | -29,047 | -25,901 | -16,833 |
| Other Working Capital | 102,219 | -19,715 | -5,708 | -17,853 | -11,297 |
| Other Operating Activity | 464,731 | 120,977 | 82,675 | 61,403 | 34,361 |
| Operating Cash Flow | $-228,763 | $55,827 | $49,760 | $10,079 | $-1,961 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -905 | -23,000 | -24,606 | -22,566 | -16,093 |
| PPE Investments | -664 | -954 | -354 | -167 | -41 |
| Purchase Sale Intangibles | -10,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -10,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-11,569 | $-23,954 | $-24,960 | $-22,733 | $-16,134 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 270,079 | 40,142 | 31,143 | 15,047 | 6,359 |
| Financing Cash Flow | $270,079 | $40,142 | $31,143 | $15,047 | $6,359 |
| Exchange Rate Effect | -1,272 | 3,222 | 3,630 | 3,281 | 1,055 |
| Beginning Cash Position | 298,165 | 222,928 | 222,928 | 222,928 | 222,928 |
| End Cash Position | 326,640 | 298,165 | 282,501 | 228,602 | 212,247 |
| Net Cash Flow | $28,475 | $75,237 | $59,573 | $5,674 | $-10,681 |
| Free Cash Flow | |||||
| Operating Cash Flow | -228,763 | 55,827 | 49,760 | 10,079 | -1,961 |
| Capital Expenditure | -664 | -954 | -354 | -167 | -41 |
| Free Cash Flow | -229,427 | 54,873 | 49,406 | 9,912 | -2,002 |